Perceptive Capital Solutions registered to offer 7.5 million shares, each priced at $10. The offering does not include warrants or rights.
The founders own 2,156,250 Class B shares and the sponsor has committed to buying 275,000 Class A shares.
The sponsor is an affiliate of Perceptive Advisors, a life sciences-focused investment firm with over $7.8 billion of regulatory assets under management as of Dec. 31, according to the filing.
Perceptive Capital will focus on healthcare or healthcare-related industries. In particular, the company is targeting North American or European companies in the life sciences and medical technology sectors where management has extensive investment experience.
Board Chairman Joseph Edelman is founder, CEO and portfolio manager of Perceptive Advisors.
The new SPAC intends to apply for a Nasdaq listing under the ticker symbol PCSC.
Jefferies is sole book-running manager on this deal. Read more.
